Jiang Zhong Pharmaceutical Co Ltd
SSE:600750

Watchlist Manager
Jiang Zhong Pharmaceutical Co Ltd Logo
Jiang Zhong Pharmaceutical Co Ltd
SSE:600750
Watchlist
Price: 21.99 CNY 0.96%
Market Cap: 13.8B CNY
Have any thoughts about
Jiang Zhong Pharmaceutical Co Ltd?
Write Note

Jiang Zhong Pharmaceutical Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jiang Zhong Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Jiang Zhong Pharmaceutical Co Ltd
SSE:600750
Net Income (Common)
ÂĄ753.2m
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
15%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Net Income (Common)
ÂĄ3.3B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Net Income (Common)
ÂĄ3.1B
CAGR 3-Years
9%
CAGR 5-Years
18%
CAGR 10-Years
23%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Net Income (Common)
ÂĄ5.4B
CAGR 3-Years
-5%
CAGR 5-Years
2%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Net Income (Common)
ÂĄ4.3B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
6%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Net Income (Common)
-ÂĄ780.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jiang Zhong Pharmaceutical Co Ltd
Glance View

Market Cap
13.8B CNY
Industry
Pharmaceuticals

Jiang Zhong Pharmaceutical Co Ltd. has etched its mark in the bustling landscape of China's pharmaceutical industry by embracing a strategic blend of traditional Chinese medicine (TCM) and modern medical practices. Founded in 1969 and headquartered in Wuhan, this company has steadily navigated the dynamic tides of China's healthcare sector. Jiang Zhong specializes in producing and marketing a wide array of TCM products, which are deeply rooted in ancient Chinese medical philosophies and practices. These offerings cater to various health needs, including gastrointestinal management, respiratory treatments, and nutritional supplements, which resonate well with China's rich cultural heritage of natural health solutions. The company's commitment to quality and efficacy has allowed it to carve out a substantial market niche where tradition meets innovation. Making money for Jiang Zhong Pharmaceutical Co Ltd. revolves around its robust distribution networks and strong brand presence across key domestic markets. The company has invested in extensive research and development initiatives to ensure its product line remains relevant and effective in addressing modern health challenges, alongside its traditional product offerings. By leveraging a diverse marketing strategy that includes partnerships with healthcare institutions, direct consumer promotions, and digital platforms, Jiang Zhong successfully taps into both local and international markets. Additionally, the company enhances its profitability through economies of scale and strategic cost management, allowing it to maintain competitive pricing while achieving substantial revenue growth. This balanced approach of blending tradition with innovation continues to fortify Jiang Zhong Pharmaceutical's position as a respected entity in both TCM and broader pharmaceutical realms.

Intrinsic Value
26.49 CNY
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Jiang Zhong Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
753.2m CNY

Based on the financial report for Sep 30, 2024, Jiang Zhong Pharmaceutical Co Ltd's Net Income (Common) amounts to 753.2m CNY.

What is Jiang Zhong Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
15%

Over the last year, the Net Income (Common) growth was 11%. The average annual Net Income (Common) growth rates for Jiang Zhong Pharmaceutical Co Ltd have been 13% over the past three years , 9% over the past five years , and 15% over the past ten years .

Back to Top